Found 224 matching trials
Chemotherapy Based on PET Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma PHASE2 RATIONALE: Drugs used in chemotherapy, such as doxorubicin hydrochloride, b...
Show More Location
Stanford Cancer Center
Learn More & Join Trial
Pre-operative Chemotherapy Plus Bevacizumab With Early Salvage Therapy Based on PET Assessment of Response in Patients With Locally Advanced But Resectable Gastric and GEJ Adenocarcinoma PHASE2 This study is being done to find out how effective a new treatment strategy...
Show More Location
Memorial Sloan Kettering Cancer Center
Learn More & Join Trial
FDG-PET/CT Scans in Patients With Stage IIIB or Stage IV NSCLC Undergoing Chemotherapy NA RATIONALE: Diagnostic procedures, such as fludeoxyglucose F 18 (\^18FDG) po...
Show More Location
Jonsson Comprehensive Cancer Center at UCLA
Learn More & Join Trial
BIOMARKER and IMAGING CHARACTERISATION of INFLAMMATORY ATHEROMA in PATIENTS RECEIVING IMMUNOTHERAPY and ANGIOGENESIS INHIBITORS N/A The advent of immunotherapy (immune checkpoint inhibitors \[ICI\]) has been...
Show More Status
Active Not Recruiting
Location
Beatson West of Scotland Cancer Centre
Learn More & Join Trial
Contribution of PET/MRI in Locally Advanced Cervical Cancer (ATICC) N/A \[18 F\]fluorodeoxyglucose (18F-FDG) positron emission tomography-magnetic ...
Show More Location
Institut de cancérologie Strasbourg Europe
Learn More & Join Trial
Functional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer PHASE2 This phase II trial tests the accuracy of functional imaging (FFNP)-positro...
Show More Location
Siteman Cancer Center at Washington University
Learn More & Join Trial
FDG-Labeled PET Scan in Planning Chemotherapy in Treating Patients With Stage IIIB or IV Non-Small Cell Lung Cancer PHASE2 This phase II trial studies how well fludeoxyglucose F 18 (FDG)-labeled pos...
Show More Location
Harborview Medical Center
Learn More & Join Trial
Pilot Prospective Study for PET-CT Imaging in Participants With Relapsed/Refractory Acute Leukemias N/A Background
Acute lymphoblastic leukemia (ALL) accounts for about 25 percen...
Show More Location
National Institutes of Health Clinical Center
Learn More & Join Trial
Diagnostic Significance of FDG PET/CT Dynamic Imaging in Detecting Metastatic Lymph Nodes With Papillary Thyroid Cancer. NA The aim of this study is to make up for the gap by performing a dynamic sca...
Show More Location
Fifth Affiliated Hospital, Sun Yat-Sen University
Learn More & Join Trial
Fluorine F 18 Fluorodopa-Labeled PET Scan in Planning Surgery and Radiation Therapy in Treating Patients With Newly Diagnosed High- or Low-Grade Malignant Glioma EARLY_PHASE1 RATIONALE: New imaging procedures, such as fluorine F 18 fluorodopa-labeled...
Show More Learn More & Join Trial